News | August 12, 2022
Apollo Hospitals posts Q1 FY23 consolidated PAT at Rs. 317.11 Cr
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
Apollo Hospital Group completed the acquisition of a hospital asset in Gurugram for a consideration of around Rs 450 crore.
An algorithm based testing for Fatty Liver Disease
The AICVD tool can predict the risk of cardiovascular disease.
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol.
It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins
The findings support the fact that further extension of nationwide cardiovascular disease (CVD) risk identification programs and prevention strategies to reduce the occurrence of cardiovascular diseases are warranted
The Cidmus brand shall be affixed on the pharmaceutical composition comprising a combination of Valsartan and Sacubitril (currently under Novartis patent) which is indicated for heart failure patients with reduced ejection fraction
OxemiaTM (Desidustat) is an oral tablet formulation that is the first-in-India alternative to injectable erythropoietin-stimulating agents (ESAs)
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
Subscribe To Our Newsletter & Stay Updated
